Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 343, Issue 3, Pages 215-219Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MAJ.0b013e31824390b9
Keywords
Ghrelin; Insulin; K-ATP channel; Kir; Expression
Categories
Ask authors/readers for more resources
Introduction: The objective is to investigate the influence of ghrelin administration on both the insulin secretion and the expression of ATP-sensitive K+ channels in islet. Methods: Ghrelin and [D-Lys(3)] growth hormone releasing peptide-6 were administered via intraperitoneal injection in Wistar rats at the doses 10 and 10 mu mol/kg/d for 2 weeks, respectively. Then glucose tolerance tests were performed and plasma insulin concentrations were measured. Islets were isolated for insulin release experiments. Single beta cells were isolated for electro-physiological experiments. Determination of the Kir6.2 and SUR1 mRNA and protein expression levels in islets was performed by polymerase chain reaction and western blotting. Results: Intraperitoneal administration of exogenous ghrelin significantly (P < 0.05) increased blood glucose concentrations, attenuated insulin responses during glucose tolerance tests, reduced insulin release from the isolated islets induced by 11.1 and 16.7 mmol/L glucose, hyperpolarized the resting membrane potential and increased the Kir6.2 mRNA and protein expression levels. In contrast, counteraction of ghrelin by intraperitoneal injection of [D-Lys(3)] growth hormone releasing peptide-6 significantly (P < 0.05) attenuated the aforementioned changes. SUR1 expression levels were not altered in this study. Conclusions: Ghrelin via pancreatic growth hormone secretagogue receptor up-regulates the Kir6.2 expression in islet by hyperpolarizing the resting membrane potential which results in the inhibition of insulin release.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available